Motivational Interviewing for Physical Activity

January 13, 2026 updated by: M.D. Anderson Cancer Center

Peer-support Motivational Interviewing Physical Activity Intervention for African American Women

The goal of this behavioral research study is to learn why some African American (AA) women choose not to exercise often and to learn if teaching African American women how to support the exercise habits of a partner will increase their physical activity and help them to stay more active over time.

The primary goal of the proposed intervention is:

Aim 1: To conduct formative research using semi-structured in-depth interviews and focus groups with sedentary AA women to investigate the role and importance of social support for PA;

Aim 2: To determine the feasibility of recruiting and implementing "Culturally Appropriate Physical Activity Motivational Interviewing" (CAPMI) intervention in sedentary AA women;

Aim 3: To pilot test and evaluate the efficacy of the CAPMI in increasing PA, social support, self-efficacy and reducing barriers to Physical Activity (PA) at post-intervention compared to an attention control group.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Focus Group:

If you agree to take part in this study, you will take part in a focus group or individual interview. A focus group is a group of people who are asked questions about certain topics and then discuss these topics with other group members. During the focus group, you will talk about ways that African American women may increase their physical activity. You will also be asked questions about the ways in which you support other women to help them become more physically active. There will be 4 focus groups, each made up of 8-10 women. The focus group session should take 1 1/2 to 2 hours.

The focus group will be audiotaped and transcribed (the spoken words will be typed up). Your individual name will not be used during the focus group and will not be recorded. For example, you will be listed as Participant #1. After the focus group comments are copied down, the focus group tapes will be destroyed. The study staff may also interview you alone. During the individual interview, you will talk about ways that African American women may increase their physical activity. You will also be asked questions about the ways in which you support other women to help them become more physically active. The staff will interview 10 women. The individual interview should take 1 1/2 to 2 hours.

The individual interview will be audiotaped and transcribed. Your individual name will not be used during the interview and will not be recorded. For example, you will be listed as Participant #1. After the interview comments are copied down, the interview tapes will be destroyed.

Length of Study:

You will be on study until you complete the focus group session.

This is an investigational study. Up to 40 women will take part in the focus groups. All will be enrolled at M. D. Anderson.

Intervention:

You will need a partner (a female friend or family member) to take part in this study. Both you and your study partner will need to meet the same eligibility requirements, and both of you will be enrolled as participants. If you choose a partner that is not eligible, you will will need to choose another eligible partner before you can be enrolled in the study.

Screening:

Before you can take part in this study, you will be asked if you are between the ages of 18 and 65 years old, if you are currently not engaging in physical activity for more than 3 days per week and more than 20 minutes each day, and if you are ready to be physically active. You will be asked if you have a home address where information can be mailed, are able to read at a 6th grade level, and are able to participate in a training course that will take place on a weekend.

You will also be asked if you are pregnant or plan to become pregnant during the next 12 weeks. You will also be asked if you plan to move outside of the Houston area in the next 12 weeks. If you are pregnant, plan to become pregnant, and/or plan to move, you will not be able to take part in this study.

Baseline Tests:

If you are found to be eligible to take part in this study, you will complete the following tests and procedures:

  • You will be asked how you are feeling and how often you exercise.
  • Your height and weight will be measured.
  • You will fill out a questionnaire about issues related to your physical activity. It will take 45-60 minutes to complete.
  • You will take a walking test, in which you will walk for 6 minutes at a comfortable pace.
  • You will receive a pedometer (a monitor that shows how far you walk).
  • You may receive an accelerometer and complete a 7-day accelerometer assessment. An accelerometer is a small device that is worn on your hip that measures the amount of physical activity you do.

Study Groups:

You will be randomly assigned (as in the flip of a coin) to 1 of 2 groups. You will have an equal chance of being assigned to either group.

Group 1:

If you are in Group 1, you will take part in an 8-hour training course conducted as 2 in-person 4-hour sessions (for example, scheduled on 2 Saturdays in a row) to help you learn how to support the exercise habits of your study partner. At this course, a trainer will give you information and you will take part in activities with your study partner. Sample activities include role playing and watching a video. This will take place on a weekend. The goal of the training course is to help you and your partner engage in physical activity. You will be asked to be physically active for 30 minutes each day.

You will receive a workbook and a DVD about physical activity. You will also be given a form to complete each time you speak with your study partner about physical activity. You will be asked to speak with your partner at least 1 time a week about your physical activities.

Each week during Weeks 1-4, 8, and 12 you will be asked to answer questions on the form given to you at the training course about the conversations you have with your study partner, and to complete recorded conversations via toll-free number. All telephone diaries must be completed and returned to research staff members by week 12 of the study.

At Weeks 4 and 8, you will be called and asked several questions about your mood and your physical activity. The phone call should take about 45 minutes.

At Weeks 5 and 9, you will be mailed a physical activity newsletter.

Group 2:

If you are in Group 2, at Weeks 4 and 8, you will be called and asked several questions about your mood and your physical activity. The phone call should take about 45 minutes.

At Weeks 5 and 9, you will receive a physical activity newsletter.

End-of-Study Visit:

At Week 12 of the study, you will complete the following tests and procedures:

  • You will be asked several questions about your mood and your physical activity.
  • Your height and weight will be measured.
  • You will take a walking test, in which you will walk for 6 minutes at a comfortable pace.
  • You may receive an accelerometer and complete a 7-day accelerometer assessment. An accelerometer is a small device that is worn on your hip that measures the amount of physical activity you do.

Length of Study You will be on study for 12 weeks.

This is an investigational study. Up to 80 women will take part in this study. All will be enrolled at M. D. Anderson.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
80

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas MD Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. African American (AA) woman (self-defined by participant) ages 18-65 years
  2. Currently sedentary, defined as self-reported PA <3 days/week for <20 minutes/day over the past 6 months
  3. Be ready and physically able to start being physically active, i.e., in preparation stage of change.
  4. Have a home address where information can be mailed and working telephone.
  5. Able to read English at a sixth-grade level as assessed by the Rapid Estimate of Adult Literacy in Medicine (REALM)
  6. Identify a sedentary AA female (i.e., non-intimate family member or friend) with whom they can enroll in the study
  7. Both partners are required to meet the same eligibility requirements and both partners will be enrolled as participants. Each woman will complete the same consent form.
  8. Be available to participate in weekend trainings

Exclusion Criteria:

  1. Currently taking medication for blood pressure or heart condition, or other physical limitations that might be aggravated by participation in moderate-intensity PA as measured using the PA Readiness Questionnaire
  2. Pregnant or thinking about becoming pregnant during the study period
  3. Thinking about moving to a location outside the greater Houston area during the study period
  4. Being unable to attend the CAPMI training sessions with their partner
  5. Participated in Phase I focus group/interviews
  6. Being a male

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Focus Group
Qualitative interviews examining social support for PA conducted with African American (AA) women recruited from Wheeler Avenue Baptist Church located in Houston used to design Culturally-Appropriate Peer-based Motivational Interviewing (CAPMI) intervention.
Active Comparator: Intervention Group 1
CAPMI Intervention: Training + Weekly Partner Questionnaire + Interview + PA Newsletter
Behavioral: Training
In-person 8-hour group physical activity training session (either over 1 or 2 days) and receive workbook and pedometer.
Behavioral: Questionnaire
Weekly during Weeks 2-7, complete question form given at training course about conversations with study partner, 5 minutes to complete.
Behavioral: Interview
Weeks 4 and 8, 30 minute phone interview about mood and physical activity.
Behavioral: PA Newsletter
At Weeks 5 and 9, receive a physical activity (PA) newsletter.
Active Comparator: Intervention Group 2
Interview + PA Newsletter
Behavioral: Interview
Weeks 4 and 8, 30 minute phone interview about mood and physical activity.
Behavioral: PA Newsletter
At Weeks 5 and 9, receive a physical activity (PA) newsletter.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Self-reported Minutes of Moderate-intensity Physical Activity per Week
Time Frame: 7 days
7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
M.D. Anderson Cancer Center

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
National Cancer Institute (NCI)
National Institutes of Health (NIH)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Lorna H. McNeill, PhD, MPH, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 28, 2009

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 31, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 31, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 4, 2009

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 5, 2009

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 6, 2009

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 14, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 13, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2008-0257
  • NCI-2012-02123 (Registry Identifier: NCI CTRP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings